Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
BVAXF
Primary Symbol:
C.BIOV
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jun 03, 2022 10:52am
Note this part of the nr
BioVaxys and Ohio State were recently invited by The Coalition for Epidemic Preparedness Innovations ("CEPI") to present their strategy for a pan-sarbecovirus vaccine to a panel of
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jun 03, 2022 10:42am
Yes and the vaccines for pan SARS/COVID and cancer
would be the worlds first.
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(4)
•••
mba123ccu
X
View Profile
View Bullboard History
Comment by
mba123ccu
on Jun 03, 2022 9:12am
RE:News BioVaxys and The Ohio State University Progress
Making progress, albeit slowly but research takes time and money and sometimes they're not always successful. Hopefully, BIOV and it's collaborator, Ohio State Univ., will be successful and
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jun 03, 2022 8:31am
News BioVaxys and The Ohio State University Progress
BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program Pan-Sarbecovirus Vaccines Identified by WHO as a Critical Need VANCOUVER, BC, June 3, 2022
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 03, 2022 8:00am
New Press Release - BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program
Pan-Sarbecovirus Vaccines Identified by WHO as a Critical NeedVANCOUVER, BC, June 3, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that The Ohio State University ("Ohio State"), its research collaborator that is...
read article.
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jun 02, 2022 11:37pm
Key Role of T Cells in the Successful Immune Responses again
Key Role of T Cells in the Successful Immune Responses against SARS-CoV-2 Infection https://www.cell.com/trends/immunology/fulltext/S1471-4906%2820%2930260-X
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on May 30, 2022 12:07am
Ovarian cancer
https://gulfnnews.com/advanced-clinical-trials-focus-on-development-of-vaccines-to-prevent-ovarian-cancer-progression-streetinsider-com/
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on May 29, 2022 10:35pm
Vaccine
https://darik.news/ohio/biovaxys-technology-corp-announces-bioproduction-of-bvx-1021-for-its-pan-serbecovirus-vaccine-program-with-ohio-state-university/202203550346.html
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on May 27, 2022 3:16am
hpv vaccine
https://www.precisionvaccinations.com/vaccines/hpv-vaccines
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on May 19, 2022 9:19pm
Ovarian cancer
https://www.medindia.net/health-press-release/advanced-clinical-trials-focus-on-development-of-vaccines-to-prevent-ovarian-cancer-progression-583845-1.htm
(12)
•••
frankman
X
View Profile
View Bullboard History
Comment by
frankman
on May 19, 2022 1:36pm
RE:Pershing your other mkt .13 trades went through
12:45:36 U 0.13 0.005 6,500 143 Pershing 1 Anonymous 12:45:36 U 0.13 0.005 3,000 143 Pershing
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on May 19, 2022 1:32pm
Pershing your other mkt .13 trades went through
12:45:36 U 0.13 0.005 6,500 143 Pershing 1 Anonymous 12:45:36 U 0.13 0.005 3,000 143 Pershing
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on May 19, 2022 8:52am
First patient enrollrd for pre screening next week
HCL has pre-screened the first patient for tumor collection, with patient enrollment for surgical debulking planned for next week. BioVaxys Confirms First Clinical Site and Principal
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on May 18, 2022 2:53pm
Asks .13 up
Ask 0.15 24,500 3 0.145 1,000 1 0.14 11,000 2 0.135 5,000 2 0.13
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income